CPT® Code 80302

Deleted

1. Indications

The CPT® Code 80302 is indicated for use in various clinical scenarios where the identification of a specific drug class from Drug Class List B is necessary. This may include situations such as:

• Substance Abuse Evaluation to assess potential drug use in patients.
• Monitoring Treatment Compliance in patients undergoing therapy for substance use disorders.
• Pre-employment Screening to ensure candidates are not using prohibited substances.
• Post-Accident Testing to determine if drug use contributed to an incident.
• Clinical Assessment in cases of suspected overdose or adverse drug reactions.

2. Procedure

The procedure for CPT® Code 80302 involves several key steps to ensure accurate drug screening. These steps include:

• Sample Collection involves obtaining a urine sample, although other biological specimens such as blood, saliva, hair, or sweat may also be used. Proper collection techniques must be followed to avoid contamination and ensure the integrity of the sample.
• Sample Preparation requires the laboratory to prepare the sample for analysis. This may involve dilution or other preparatory steps to ensure that the sample is suitable for the chosen testing method.
• Testing Method Selection involves choosing the appropriate analytical technique, such as ELISA, GC, or HPLC, based on the specific requirements of the test and the substances being screened.
• Analysis is conducted using the selected method. For ELISA, the sample is mixed with antibodies that bind to the target analytes, producing a measurable signal. In GC, the sample is vaporized and passed through a column to separate the components, while HPLC uses solvents to move analytes through a column for separation and identification.
• Result Interpretation involves analyzing the data obtained from the testing method to determine the presence or absence of the specified drug class. Results are then documented and reported to the requesting physician or healthcare provider.

3. Post-Procedure

After the completion of the drug screening procedure under CPT® Code 80302, the laboratory will provide a report detailing the findings. It is essential for healthcare providers to review the results in conjunction with the patient's clinical history and other relevant information. Follow-up actions may include further confirmatory testing if the presumptive test indicates a positive result, as well as discussions with the patient regarding the implications of the findings. Additionally, proper documentation of the procedure and results is crucial for compliance and billing purposes.